A
ASTH
Astrana Health
34.98
+0.09+0.26%After Hours: 34.98 0.00 0.00%16:10 05/04 EDT
OPEN/PREV CLOSE35.26/35.25
TODAY RANGE35.13-36.20
VOL614.33K
MARKET CAP2.01B
52 WEEK RANGE18.08-36.20
AVG VOL (3M)493.84K
% TURNOVER1.10%
TURNOVER--
P/E (TTM)79.21
% RANGE3.04%
EPS(TTM)0.4555
P/E(FORWARD)29.10
P/B2.263
BVPS15.94
DIVIDEND--
P/S0.5543
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.60B
SHARES OUTSTANDING55.71M
NEXT EARNINGS05/06-05/11
FREE FLOAT44.39M
LOT SIZE1
EX-DATE04/27/2015
News
Press Releases
Financial Reports
Profile
TipRanks·7h ago
Astrana Health sees Q2 revenue $965M-$1B, consensus $973.68M
Reuters·7h ago
Astrana Health Q1 revenue beats estimates
Dow Jones·8h ago
*Astran Health Sees 2Q Rev $965M-$1B
Dow Jones·8h ago
*Astran Health 1Q Adj EPS 74c
Dow Jones·8h ago
*Astran Health 1Q EPS 29c
PUBT·04/17 10:06
Astrana Health announces annual shareholder meeting```
TipRanks·04/16 11:37
Truist Financial Keeps Their Buy Rating on Astrana Health (ASTH)
Dow Jones·04/15 11:12
Astrana Health Is Maintained at Outperform by Baird
Benzinga·04/15 11:02
Baird Maintains Outperform on Astrana Health, Raises Price Target to $40
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.